Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMUR2 | Q9GZQ4 | 2/20 | 0.34 |
| ▸ | CDC14B | O60729 | 1/20 | 0.34 |
| ▸ | CDC14A | Q9UNH5 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.33 |
| ▸ | EGFR | P00533 | 1/20 | 0.33 |
| ▸ | GABRP | O00591 | 1/20 | 0.33 |
| ▸ | GABRD | O14764 | 1/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.33 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.33 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.33 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.33 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.33 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.33 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.33 |
| ▸ | GABRE | P78334 | 1/20 | 0.33 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.33 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.33 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21343983 | 0.81 | NMUR2 (0.35) | NMUR2ALOX5EGFRGABRPGABRD | |
| SCHEMBL19110415 | 0.81 | NMUR2 (0.34) | NMUR2ALOX5EGFRGABRPGABRD | |
| SCHEMBL21102568 | 0.79 | ALOX5 (0.45) | NMUR2ALOX5EGFRGABRPGABRD | |
| SCHEMBL26469931 | 0.79 | ALOX5 (0.35) | CDC14BCDC14AALOX5MAOAIDO1 | |
| SCHEMBL22004808 | 0.78 | NMUR2 (0.34) | NMUR2CDC14BCDC14AALOX5EGFR | |
| SCHEMBL16683879 | 0.77 | PDK2 (0.39) | PDK2CYP2C19 | |
| SCHEMBL18926952 | 0.77 | PDK2 (0.36) | NMUR2CDC14BCDC14AALOX5EGFR | |
| SCHEMBL21350243 | 0.76 | AHR (0.35) | NMUR2ALOX5EGFRGABRPGABRD | |
| SCHEMBL21343240 | 0.76 | AHR (0.35) | NMUR2ALOX5EGFRGABRPGABRD | |
| SCHEMBL9916959 | 0.76 | ALOX5 (0.52) | NMUR2ALOX5EGFRGABRPGABRD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11683980-B2 | Condensed fluorene derivative comprising heterocyclic ring | SFC CO., LTD. (KR) | 2023-06-20 | — | — | US | disclosed |
| US-11683980-B2 | Condensed fluorene derivative comprising heterocyclic ring | SFC CO., LTD. (KR) | 2023-06-20 | — | — | US | disclosed |
| EP-4116297-A1 | CONDENSED FLUORENE DERIVATIVE COMPRISING HETEROCYCLIC RING | SFC Co., Ltd. (KR) | 2023-01-11 | — | — | EP | disclosed |
| US-20170222155-A1 | CONDENSED FLUORENE DERIVATIVE COMPRISING HETEROCYCLIC RING | SFC CO., LTD. (KR) | 2017-08-03 | — | — | US | disclosed |
| US-20170222155-A1 | CONDENSED FLUORENE DERIVATIVE COMPRISING HETEROCYCLIC RING | SFC CO., LTD. (KR) | 2017-08-03 | — | — | US | disclosed |
| EP-3176158-A2 | CONDENSED FLUORENE DERIVATIVE COMPRISING HETERO RING | SFC Co., Ltd. (KR) | 2017-06-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170222155-A1 | CONDENSED FLUORENE DERIVATIVE COMPRISING HETEROCYCLIC RING | CCNE2, INF2, AFF4 | NMUR2 2456/4885CDC14B 1760/4885CDC14A 1537/4885 |
| US-11683980-B2 | Condensed fluorene derivative comprising heterocyclic ring | CCNE2, INF2, AFF4 | NMUR2 2456/4885CDC14B 1760/4885CDC14A 1537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.